160 Increasing gonadotrophin-releasing hormone dose at initiation of a 5-day CO-Synch protocol increases ovulatory response but not fertility in yearling beef heifers

2020 ◽  
Vol 32 (2) ◽  
pp. 206
Author(s):  
E. Rojas Canadas ◽  
S. E. Battista ◽  
J. Kieffer ◽  
S. Wellert ◽  
A. Garcia Guerra

Heifers typically have a reduced ovulation rate following gonadotrophin-releasing hormone (GnRH) application at initiation of a CO-Synch + controlled internal drug release (CIDR) protocol. Thus, the objective of the present study was to determine whether increasing the dose of GnRH at initiation of a 5-day CO-Synch protocol in beef heifers would improve ovulation rate and therefore increase pregnancies per AI (P/AI). Angus yearling heifers (n=299) at five locations in Ohio (United States) were randomised to receive either 100µg (single; n=149) or 200µg (double; n=150) of gonadorelin acetate (Gonabreed, Parnell) at initiation of a 5-day CO-Synch. On Day −8, heifers received a new intravaginal progesterone-releasing device (1.38g of progesterone; CIDR, Zoetis) and either a single or double dose of GnRH as described above. Five days later (Day −3), devices were removed, 1000µg of cloprostenol sodium (Estroplan, Parnell) was administered, and an oestrous detection patch was applied (Estrotect, Rockway Inc.). Sixty hours after device removal, AI was performed concurrently with the administration of 100µg of GnRH. Pregnancy was determined using ultrasonography 35 days after AI. Ovaries from a subset of animals (n=178) were examined on Days −8 and −3 using ultrasonography to determine the presence of corpora lutea (CL) and the size of the largest follicle. Data were analysed using the GLIMMIX procedure of SAS ver. 9.4 (SAS Institute Inc.). Oestrous expression was similar (P=0.50) between heifers treated with a single (49.0%) or double (52.7%) dose of GnRH. Overall, P/AI was similar (P=0.35) between heifers receiving a single (43.6%; 65/149) or double (38.7%; 58/150) dose of GnRH at initiation of the protocol. However, increasing the dose of GnRH resulted in a greater (P=0.04) ovulation rate in heifers in the double-dose group (40.9%; 36/88) compared with those in the single-dose group (26.1%; 23/88). In addition, heifers with a CL at the time of treatment had reduced ovulatory response to GnRH treatment (16.0%) compared with heifers without a CL (53.7%; P=0.001); however, there was no treatment×CL presence interaction (P=0.69). Heifers that did not ovulate to the initial GnRH treatment had a greater (P=0.0008) diameter of the largest follicle on Day −3 compared with heifers that did ovulate (11.4±0.2 vs. 10.0±0.3). Furthermore, heifers that did ovulate after the initial GnRH had greater (P=0.04) P/AI (52.5%) than heifers that did not ovulate (40.2%), and heifers with a CL on Day −8 tended (P=0.07) to have greater P/AI (47.9%) than heifers without a CL (40.2%). In addition, heifers with a CL present on Day −3 had greater (P=0.04) P/AI (48.2%) than heifers without a CL (31.7%). In summary, increasing the dose of GnRH at initiation of a 5-day CO-Synch did not affect fertility to fixed-time AI but enhanced ovulation rate in beef heifers. Furthermore, heifers that did ovulate at initiation of the protocol or that had a CL at device insertion or removal had greater fertility to fixed-time AI. Thus, alternative strategies that maximise ovulation at initiation of the synchronisation protocol are needed.

2015 ◽  
Vol 27 (1) ◽  
pp. 96 ◽  
Author(s):  
A. Menchaca ◽  
R. Nuñez-Olivera ◽  
F. Cuadro ◽  
G. Bo

An oestradiol-based protocol (named J-Synch) has been developed recently with the aim of providing for a longer proestrus, enhancing the development of the dominant follicle before ovulation, and increasing pregnancy rates following fixed-time AI (FTAI) in heifers (de la Matta and Bo 2012 Taurus 55, 17–23). Two experiments were performed in Uruguay with 1953 Angus × Hereford crossbred heifers to compare pregnancy rates obtained with the J-Synch protocol with the conventional 7-day oestradiol-based protocol. A secondary objective was to determine the effects of the time of FTAI and the addition of eCG at the time progestin device removal on pregnancy rates. In Experiment 1, 966 heifers received a DIB device (0.5 g of progesterone, Syntex, Buenos Aires, Argentina) plus 2 mg of oestradiol benzoate IM (Syntex) on Day 0. Heifers in the conventional treatment group (n = 485) received cloprostenol (500 μg, Ciclase DL, Syntex) and oestradiol cypionate (0.5 mg, Cipiosyn, Syntex) IM and had their DIB removed on Day 7 a.m. Heifers in this group were then subdivided to be FTAI on Day 9 a.m. or p.m. (i.e. 48 or 56 h after DIB removal). Heifers in the J-Synch treatment group (n = 481) received cloprostenol IM and DIB removal on Day 6 p.m. and received gonadotropin-releasing hormone (100 μg gonadorelin acetate, Gonasyn Gdr, Syntex) on Day 9 a.m.; heifers were then FTAI on Day 9 a.m. or p.m. (i.e. 60 or 72 h after DIB removal). All heifers in this experiment were also treated with 300 IU of eCG (Novormon, Syntex) at DIB removal. In Experiment 2, 987 heifers were treated with the J-Synch protocol as described in Experiment 1. At device removal (Day 6 p.m.), heifers were divided to receive (n = 488) or not (n = 499) 300 IU of eCG IM at that time and were further subdivided to receive gonadotropin-releasing hormone and FTAI on Day 9 a.m. or p.m. (i.e. 60 or 72 h after DIB removal). Pregnancy rates were determined by ultrasonography 30 days after FTAI. Data were analysed using logistic regression, and results are shown in Table 1. J-Synch-treated heifers tended (P < 0.1) to have higher pregnancy rates following FTAI, whereas time of FTAI only affected pregnancy rates following the conventional 7-day treatment (P < 0.05). However, removal of eCG from the J-Synch protocol in Experiment 2 resulted in reduced pregnancy rates when inseminations were done on Day 9 p.m. (P < 0.05). In summary, the addition of eCG to the J-Synch protocol provided for a wider window of insemination times facilitating FTAI in large groups of beef heifers. Table 1.Effect of length of progestin insertion, time of insemination and eCG treatment on pregnancy rates in beef heifers


2020 ◽  
Vol 32 (2) ◽  
pp. 208
Author(s):  
A. Butler ◽  
H. Butler ◽  
G. Cesaroni ◽  
R. Alberio ◽  
S. Perez Wallace ◽  
...  

Oestrus expression between progesterone (P4) withdrawal and fixed-time AI (FTAI) has been shown to improve pregnancies per AI (P/AI) by 27% in beef cattle. As a result, cattle that do not express oestrus after P4 withdrawal present a challenge to the efficiency of FTAI. The present study was designed to test the hypothesis that administration of gonadotrophin-releasing hormone (GnRH) at the time of AI in heifers that do not express oestrus can improve fertility. Two-year-old Angus heifers (n=1032) with a condition score of 2.75 to 3.5 at two locations in Argentina were used. On Day 0, heifers received an intravaginal device containing 0.5g of P4 (Cronipres, Biogenesis) and 2mg of oestradiol benzoate intramuscularly (Bioestrogen, Biogenesis). On Day 8, devices were removed and heifers received 150µg of d-cloprostenol intramuscularly (Enzaprost, Biogenesis), 0.5mg of oestradiol cipionate intramuscularly (Croni-Cip, Biogenesis), and an oestrus detection patch (Estrotect, Rockway Inc.). On Day 10, AI was performed in all heifers 50 to 54h after device removal. Heifers were categorised based on oestrus expression, and those that did not express oestrus were randomised to receive 100µg of gonadorelin acetate intramuscularly (Gonasyn, Syntex; n=158) concurrent with AI or remain as untreated controls (n=151). Pregnancy was determined using ultrasonography at Days 38 and 111 after AI. Differences in fertility were evaluated using generalised linear mixed models, and the results are shown in Table 1. Oestrus expression between device removal and FTAI was 70.1% (723/1032). Pregnancies per AI at Days 38 and 111 were different between groups (P&lt;0.01). Heifers that expressed oestrus had greater P/AI than those that did not regardless of treatment (P&lt;0.01). However, in heifers that did not express oestrus, treatment with GnRH at the time of AI resulted in greater P/AI than in control heifers (P=0.004). Similarly, P/AI at Day 111 were greater in heifers that expressed oestrus than in those that did not regardless of treatment (P&lt;0.01). Heifers that did not express oestrus and were treated with GnRH had greater P/AI than those that did not express oestrus and remained as controls (P=0.02). Pregnancy loss between Days 38 and 111 was not different between groups; however, there was a tendency (P=0.06) for greater pregnancy loss in heifers that did not express oestrus and were treated with GnRH compared with heifers that expressed oestrus. In summary, treatment with GnRH at the time of AI is a suitable strategy to improve P/AI in heifers that fail to exhibit oestrus after an oestradiol-based synchronisation protocol. However, this strategy appears to increase pregnancy loss, and thus further research is needed to confirm this observation and the mechanisms underlying it. Table 1.Pregnancies per AI (P/AI) and pregnancy loss (%; no. in parentheses) in Angus heifers based on oestrus expression and treatment with GnRH Group P/AI Day 38 P/AI Day 111 Pregnancy loss Oestrus 68.9 (498/723)A 65.2 (471/723)A 5.4 (27/498) No oestrus control 29.8 (45/151)B 28.5 (43/151)B 4.4 (2/45) No oestrus + GnRH 45.6 (72/158)C 40.5 (64/158)C 11.1 (8/72) P-value &lt;0.001 &lt;0.001 0.15 A-CValues within a column with different superscripts differ significantly (P&lt;0.05).


2021 ◽  
Vol 33 (2) ◽  
pp. 167
Author(s):  
E. M. Zwiefelhofer ◽  
S. X. Yang ◽  
M. Asai-Coakwell ◽  
M. G. Colazo ◽  
J. Hellquist ◽  
...  

Intravaginal progesterone (P4) devices used for ovarian synchronization before fixed-time AI (FTAI) differ in drug release, which may influence fertility outcome. A 2×2 study was designed to determine the effects of different intravaginal devices (PRID Delta, 1.55g of P4 vs. CIDR, 1.38g of P4) and parity (heifers vs. cows) on follicular dynamics, expression of oestrus, and pregnancy per AI (P/AI). At random stages of the oestrous cycle, nulliparous beef heifers and lactating cows were given 100µg of gonadorelin (gonadotrophin-releasing hormone, GnRH) intramuscularly (IM) and assigned randomly to either the PRID (n=76 heifers, 76 multiparous, 27 primiparous) or CIDR (n=76 heifers, 73 multiparous, 32 primiparous) group. Devices were removed 5 days later, an oestrus-detection patch was applied just cranial to the tail head, and 500µg of cloprostenol was given IM at the time of device removal and again 24h later. At 72h after device removal, cattle were inseminated and given 100µg of GnRH IM. Transrectal ultrasonography was used to determine the diameter of the largest follicle on the day of device removal and at FTAI, ovulation time, and pregnancy status 30 days after FTAI. A colour change of ≥50% of the oestrus-detection patch at FTAI was taken as expression of oestrus. Data were compared among groups by 2-way ANOVA using MIXED and GLIMMIX procedures. There were no interactions between P4 device and parity for any endpoint. The diameter of the largest follicle (mean±s.e.m.) was not different between PRID and CIDR groups on either the day of device removal (10.6±0.1 vs. 10.9±0.1mm) or the day of FTAI (13.7±0.1 vs. 13.9±0.1mm). The proportion displaying oestrus did not differ between P4 device groups, but was greater in heifers than in cows [121/152 (79.6%) vs. 135/207 (65.2%); P&lt;0.01], and the interval from FTAI to ovulation was shorter in heifers than in cows (27.8±1.2 vs. 32.0±1.1 h; P=0.01). The P/AI was not different between P4 device groups or parity groups (overall 67.0%, 238/355). However, among lactating cows, the P/AI tended to be greater in the PRID vs. CIDR group [75/102 (73.5%) vs. 64/105 (61.0%); P=0.10], and was greater in multiparous vs. primiparous cows [106/148 (71.6%) vs. 33/59 (55.9%); P=0.04]. Among cattle that displayed oestrus, the P/AI tended to be greater in the PRID vs. CIDR group [92/123 (74.8%) vs. 85/131 (64.9%); P=0.09]. Among lactating cows that displayed oestrus, the P/AI was greater in multiparous vs. primiparous cows [74/94 (78.2%) vs. 24/42 (57.1%); P&lt;0.01]. In summary, follicular dynamics and expression of oestrus did not differ between PRID and CIDR groups, but the P/AI tended to be greater in PRID-treated lactating cows and in cattle that displayed oestrus. This research was supported by CEVA Animal Health, Saskatchewan ADF, Agriculture and Agri-Foods Canada, and Rockway Inc.


1991 ◽  
Vol 3 (1) ◽  
pp. 109 ◽  
Author(s):  
BH Pearse ◽  
NP McMeniman ◽  
KF Dowsett

In each of three experiments, thirty seasonally anoestrous Border Leicester ewes were fed on a maintenance ration of oaten chaff. Fifteen of them were given a supplement of 500 g lupin grain per head per day. The ewes were treated with 10 mg follicle stimulating hormone (Expt 1), 600 I.U. pregnant mare serum gonadotrophin (Expt 2) and either 150 or 300 micrograms gonadotrophin releasing hormone (Expt 3) to determine whether the ovaries and/or the anterior pituitary were capable of responding to the nutrient status of the animals and influencing ovulation rate. In each experiment, the number and size of corpora lutea and follicles in the lupin-supplemented and -unsupplemented groups were similar. It was concluded that the mechanism by which lupins increase the ovulation rate is probably neural and not a result of direct effect on either the pituitary or the ovaries.


1990 ◽  
Vol 70 (3) ◽  
pp. 983-985 ◽  
Author(s):  
R. N. KIRKWOOD ◽  
P. A. THACKER ◽  
L. M. RUTTER ◽  
F. X. AHERNE

Twenty-two ewes received either 30 μg GnRH or saline at the onset of estrus. Blood samples were obtained on days 1–7 (day 0 = estrus) and corpora lutea recovered surgically at day 7. There was no effect of GnRH on the number or weight of corpora lutea nor on the concentrations of progesterone in either corpora lutea or plasma. GnRH treatment caused an increase (P < 0.07) in luteal hCG binding capacity (0.66 ± 0.12 vs. 0.34 ± 0.12 nmol mg−1 protein). Key words: GnRH, estrus, corpora lutea, hCG binding


2019 ◽  
Vol 97 (Supplement_2) ◽  
pp. 124-124
Author(s):  
Jerica J J Rich ◽  
Emmalee J Northrop ◽  
Kaitlin M Epperson ◽  
Saulo Menegatti Zoca ◽  
Stephanie D Perkins ◽  
...  

Abstract Previous studies evaluating single and multiple GnRH injections at time of CIDR removal have reported decreased interval to estrus and increased expression of estrus, and increased conception rates, respectively. Thus, the objective of this study was to compare the effects of supplementing GnRH at CIDR removal on expression of estrus and conception rates in beef heifers following the 7-d CO-Synch + CIDR protocol. Heifers (n = 1,482) from 11 herds over two years were synchronized using the 7-d CO-Synch + CIDR fixed time AI (FTAI) protocol and were randomly assigned to receive one of three treatments at CIDR removal [0 µg GnRH (0); 5 µg GnRH (5); or 5 µg at CIDR removal and 5 µg 12 h later (5 + 5)]. Expression of estrus and conception rates were analyzed using the GLIMMIX procedure of SAS with treatment as an independent variable and herd as a random effect. There was no effect of treatment on expression of estrus (P = 0.38), or AI conception rates (P = 0.85). There was an effect of estrus (P < 0.01) and a treatment × estrus interaction (P = 0.02). Animals that exhibited estrus prior to FTAI had increased (P < 0.01) conception rates compared with those that did not. Animals that exhibited estrus had increased (P < 0.01) conception rates compared with non-estrus animals in the 0 and 5 + 5 µg groups (54 ± 3% vs 34 ± 3%, and 52 ± 3% vs 36 ± 3%, respectively), but in the 5 µg group, there was no difference (P = 0.53) in conception rates between estrus and non-estrus animals (44 ± 3% vs 41 ± 3%, respectively). In conclusion, estrus expression increased pregnancy success, but supplementation with 5 or 5 + 5 µg of GnRH at CIDR removal did not improve estrus response or conception rates in beef heifers.


2017 ◽  
Vol 29 (3) ◽  
pp. 468 ◽  
Author(s):  
R. M. Ferreira ◽  
H. Ayres ◽  
L. U. Gimenes ◽  
F. P. Torres ◽  
F. A. Lima ◽  
...  

The effects of addition of gonadotrophin-releasing hormone (GnRH) to a progesterone plus oestradiol-based protocol and timing of insemination in Holstein cows treated for timed AI (TAI) were evaluated. Cows (n = 481) received a progesterone device and 2 mg oestradiol benzoate. After 8 days, the device was removed and 25 mg dinoprost was administered. Cows were allocated to one of three (Study 1; n = 57) or four (Study 2; n = 424) groups, accordingly to ovulation inducer alone (Study 1; oestradiol cypionate (EC), GnRH or both) or ovulation inducer (EC alone or combined with GnRH) and timing of insemination (48 or 54 h after device removal; Study 2). In Study 1, the diameter of the ovulatory follicle was greater for GnRH than EC. Oestrus and ovulation rates were similar regardless of ovulatory stimuli. However, time to ovulation was delayed when GnRH only was used. In Study 2, cows treated with GnRH or not had similar pregnancy per AI (P/AI) 30 days (41.5% vs 37.3%; P = 0.28) and 60 days (35.9% vs 33.0%; P = 0.61) after TAI. TAI 48 and 54 h after device removal resulted similar P/AI at 30 days (40.3% vs 38.5%; P = 0.63) and 60 days (33.8% vs 35.1%; P = 0.72). Thus, adding GnRH at TAI does not improve pregnancy rates in dairy cows receiving EC. The flexibility of time to insemination enables TAI of a large number of cows using the same protocol and splitting the time of AI.


2010 ◽  
Vol 22 (1) ◽  
pp. 177 ◽  
Author(s):  
M. Ramos ◽  
L. Cutaia ◽  
P. Chesta ◽  
G. A. Bó

Two experiments were designed to evaluate the effect of the timing of fixed-time AI (FTAI) in relation to the removal of an intravaginal progesterone-releasing device (1 g of progesterone, DIB, Syntex SA, Buenos Aires, Argentina) on pregnancy rates in Bos indicus × Bos taurus cross-bred heifers. In experiment 1, 285 Bonsmara × zebu cross-bred heifers, between 18 and 24 months of age and with a body condition score (BCS) between 3.0 and 3.5 (1-5 scale) were used. On the day of initiation of treatment (Day 0), the heifers’ ovaries were palpated (92% of them had a CL) and they received a new DIB plus 2 mg of estradiol benzoate (EB; Syntex SA) and 250 μg of cloprostenol (Ciclase DL, Syntex SA). On Day 8, DIB devices were removed and all heifers received 250 μg of Ciclase plus 0.5 mg of estradiol cypionate (ECP; Cipiosyn, Syntex SA). At that time the heifers were randomly divided to receive FTAI between 48 to 49 h, 53 to 54 h, or 58 to 59 h after DIB removal. The heifers underwent FTAI with semen from 4 bulls by 2 inseminators. In experiment 2, 260 heifers from the same group as those used in experiment 1 (87% with a CL) were treated exactly as those in experiment 1, except that previously used DIB was inserted on Day 0. Pregnancy diagnosis was performed 30 days post-fixed-time AI by ultrasonography. The data were analyzed by logistic regression, taking into account the effect of time of FTAI, semen, and inseminator on pregnancy rates. In experiment 1, pregnancy rates were lower (P = 0.04) in the heifers undergoing FTAI between 48 and 49 h after DIB removal (46/95, 48.4%) than those undergoing FTAI 53 to 54 h (61/99, 61.6%) or 58 to 60 h (57/91, 62.6%) after DIB removal. However, no differences in pregnancy rates were found (P = 0.72) in experiment 2 between the 3 treatment groups, with 39/91 (42.9%) for the 48 to 49 h group, 45/89 (50.6%) for the 53 to 54 h group, and 35/89 (43.8%) for the 58 to 59 h group. There was no effect of the semen or inseminator (P > 0.2) in either experiment. We conclude that when Bos indicus × Bos taurus beef heifers are synchronized with new DIB devices and ECP, higher pregnancy rates are obtained in heifers undergoing FTAI late (between 53 to 60 h after DIB removal) than in those undergoing FTAI early (48 to 49 h after DIB removal). However, time of insemination does not apparently affect pregnancy rates when Bos indicus × Bos taurus beef heifers are synchronized with previously used DIB devices and ECP.


2021 ◽  
Vol 33 (2) ◽  
pp. 161
Author(s):  
E. R. Canadas ◽  
B. J. Duran ◽  
G. Machado ◽  
A. Nall ◽  
S. E. Battista ◽  
...  

Ovulatory response to the initial gonadotrophin-releasing hormone (GnRH) of the CO-Synch protocol is affected by circulating progesterone (P4) and follicle size. In addition, heifers that ovulate to the initial GnRH treatment have greater fertility after AI. Thus, this study determined the effect of (1) presynchronization (Presynch) before a 6-day CO-Synch protocol and (2) circulating [RCE1] (P4) on ovulatory response, oestrus expression, and pregnancies per AI (P/AI) in beef heifers. Yearling beef heifers (n=233) at three locations were randomly assigned in a 2×2 factorial design to the following treatments: (1) Presynch+6-day CO-Synch with a new P4 device; (2) Presynch+6-day CO-Synch with a once-used P4 device; (3) 6-day CO-Synch with a new P4 device; and (4) 6-day CO-Synch with a once-used P4 device. Presynch consisted of insertion of a new P4 intravaginal device (1.38g of P4) on Day −17 and removal of P4 device on Day −11 concurrently with 500µg of cloprostenol sodium (PGF). On Day −9, all heifers received either a new (New) or once-used (Used) CIDR and 100µg of gonadorelin acetate (GnRH). Six days later (Day −3), CIDRs were removed, 1000µg of PGF was administered and an oestrous detection patch applied (Estrotect). At 72h after CIDR removal, AI was performed concurrently with administration of 100µg of GnRH. Pregnancy was determined by transrectal ultrasonography 31 days after AI. A subset of heifers (n=155) was examined on Day −9 and Day −3 by ultrasonography to determine ovulation to Day −9 GnRH. Data were analysed using generalized linear mixed models (SAS 9.4; SAS Institute Inc.). Presynch heifers had larger follicle diameter on Day −9 (12.7±0.3 vs. 10.1±0.3 mm; P&lt;0.001), greater ovulatory response to Day −9 GnRH (82.5%; 66/80 vs. 56%; 42/75; P&lt;0.001), greater expression of oestrus (90.6%; 106/117 vs. 78.4%; 91/116; P&lt;0.02), and earlier oestrus (49.8±1 vs. 53.1±1 h; P&lt;0.01) compared with controls. There was a treatment×CIDR interaction on oestrous expression, such that a lesser (P&lt;0.05) percentage of control heifers with new CIDR expressed oestrus compared with all other groups (Table 1). Heifers with a used CIDR during the 6-day CO-Synch tended (P=0.08) to have greater P/AI (52.1%; 61/117) than those with a new CIDR (40.5%; 47/116). In conclusion, presynchronization before initiation of a 6-day CO-Synch increased follicle diameter, enhanced ovulatory response and oestrous expression, but did not affect fertility. The earlier onset of oestrus in presynchronized heifers suggests that the timing of AI may need to be modified. Table 1. Oestrous expression and pregnancy per AI (P/AI) in beef heifers with or without presynchronization and treated with a new or used CIDR during a 6-day CO-Synch Treatment CIDR Oestrus (%; n/n) Time of oestrus (h) P/AI (%; n/n) Control New 67.8a (40/59) 53.7±1.5a 33.9 (20/59) Used 89.5b (51/57) 52.7±1.6a 50.9 (29/57) Presynch New 94.7b (54/57) 50.9±1.4b 47.4 (27/57) Used 86.7b (52/60) 48.7±1.3b 53.3 (32/60) P-value Treatment 0.03 0.01 0.21 CIDR 0.62 0.19 0.08 Interaction 0.003 0.75 0.38 a,bValues with different superscripts differ (P&lt;0.05).


2017 ◽  
Vol 29 (1) ◽  
pp. 111 ◽  
Author(s):  
G. A. Bó ◽  
A. Cedeño ◽  
A. Tribulo ◽  
S. Andrada ◽  
R. Tribulo ◽  
...  

We have previously shown that expression of oestrus significantly influences the time of ovulation and pregnancy rates to timed-AI (P/TAI) in beef cattle synchronized with progesterone devices and oestradiol (Bó et al. 2016 Theriogenology 86, 388–396). Furthermore, delaying TAI from 48 h to 54–58 h after device removal improved P/TAI of those animals not showing oestrus by 48 h. The objective of the present study was to determine whether the administration of GnRH to those animals not showing oestrus by 48 h after device removal had an impact on P/TAI. Non-lactating and suckled beef cows and heifers (Bonsmara, Brangus, and Braford; n = 868), with a corpus luteum (CL) or a follicle ≥8 mm in diameter detected by ultrasonography (Mindray DP 30 Vet, 7.5 MHz, China) and body condition score 2 to 4 (1 to 5 scale) were synchronized in 3 replicates. On Day 0, animals received a progesterone device (DIB 0.5 g, Zoetis, Argentina) and 2 mg of oestradiol benzoate (Von Franken, Argentina). On Day 8, DIB were removed and cows received 0.150 mg of D+cloprostenol (Río de Janeiro, Argentina) plus 0.5 mg oestradiol cypionate (Cipiosyn, Zoetis). In addition, all cows were tail-painted on the sacrococcygeal area (CeloTest, Biotay, Argentina) at DIB removal and were observed to determine the expression of oestrus, according to the percentage of paint loss (PL) 48 h later. The animals that showed oestrus (PL > 30%) were recorded and TAI at that time while those with PL ≤ 30% (not in oestrus) were randomly allocated to receive 100 μg of gonadorelin (GnRH; Gonasyn, Zoetis) or no treatment and TAI between 54 to 58 h after DIB removal. Pregnancy was diagnosed by ultrasonography at 45 days after TAI, and data were analysed by logistic regression. There were no significant differences among replicates, inseminators, semen source or animal class (dry cows, suckled cows or heifers; P > 0.11). However, animals showing oestrus by 48 h after DIB removal had higher P/TAI (371/666; 55.7; P < 0.04) than those that did not show oestrus (96/202; 47.5%). Within animals not showing oestrus at 48 h, those that were in oestrus by the TAI at 54 to 58 h had higher P/TAI (71/124, 57.3%; P < 0.01) than those that did not show oestrus within that period (27/78; 34.6%). In addition, P/TAI was higher (P < 0.01) in animals that received GnRH (66/113; 58.4%) than in those that did not receive GnRH (30/89; 33.7%). In conclusion, the expression of oestrus significantly affected P/TAI in beef cattle synchronized with progesterone devices and oestradiol. Furthermore, treatment of animals not showing oestrus by 48 h after DIB removal with GnRH resulted in improved P/TAI performed 6 to 10 h later.


Sign in / Sign up

Export Citation Format

Share Document